ストックスクリーナーアプリを入手
72.87
1.96%
-1.46
前日終値:
$74.33
開ける：
$74.28
24時間の取引高:
664.12K
Relative Volume:
0.66
時価総額：
$7.68B
収益：
$628.56M
当期純損益:
$141.82M
株価収益率:
57.83
EPS:
1.26
ネットキャッシュフロー:
$142.60M
1週間 パフォーマンス:
+5.06%
1か月 パフォーマンス:
-0.98%
6か月 パフォーマンス:
+32.49%
1年 パフォーマンス:
+104.06%
1日の値動き範囲:
$71.61
$74.79
1週間の範囲:
$67.32
$74.79
52週間の値動き範囲:
$35.87
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
名前
Corcept Therapeutics Inc
セクター
電話
650.688.8803
住所
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
CORT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
72.87 | 7.55B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-06 | アップグレード | Truist | Hold → Buy |
| 2023-04-11 | 開始されました | SVB Securities | Market Perform |
| 2023-04-04 | 開始されました | Piper Sandler | Overweight |
| 2023-02-15 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-01 | ダウングレード | Truist | Buy → Hold |
| 2022-07-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-06-27 | 再開されました | Canaccord Genuity | Buy |
| 2022-02-02 | 開始されました | Canaccord Genuity | Buy |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-09-24 | 開始されました | Jefferies | Buy |
| 2019-09-06 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-04 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 繰り返されました | Stifel | Hold |
| 2018-05-31 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-09 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 開始されました | Stifel | Buy |
| 2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-04-21 | 開始されました | FBR Capital | Outperform |
| 2014-01-13 | ダウングレード | Stifel | Buy → Hold |
| 2013-08-09 | ダウングレード | Janney | Buy → Neutral |
| 2013-08-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2010-01-06 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | アップグレード | Punk, Ziegel & Co | Mkt Perform → Accumulate |
すべてを表示
Corcept Therapeutics Inc (CORT) 最新ニュース
Scientech Research LLC Sells 4,716 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
AQR Capital Management LLC Sells 23,561 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Analysts Set Corcept Therapeutics Incorporated (NASDAQ:CORT) Price Target at $134.50 - MarketBeat
FDA Accepts Corcept's NDA for Relacorilant in Ovarian Cancer - sharewise.com
Bayforest Capital Ltd Acquires 5,739 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Empowered Funds LLC Has $13.97 Million Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept’s (CORT) Multibagger Momentum Builds on Relacorilant and Expanding Commercial Footprint - Insider Monkey
FDA Accepts NDA for Relacorilant in Platinum-Resistant Ovarian Cancer - Targeted Oncology
Central serous chorioretinopathy Pipeline Analysis & Clinical - openPR.com
Central serous chorioretinopathy Pipeline Analysis & Clinical Trials, 2025, DelveInsight | Targeted Therapy Technologies, Corcept Therapeutics, Bayer, and others - Barchart.com
Jacobs Levy Equity Management Inc. Decreases Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Coppell Advisory Solutions LLC Purchases 14,590 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept's ovarian cancer treatment under FDA review (CORT) - Seeking Alpha
Corcept Therapeutics Says FDA Accepts NDA on Relacorilant for Treating Ovarian Cancer - MarketScreener
Fda reviews Corcept's nda for relacorilant in drug-resistant ovarian cancer - MarketScreener
FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer - Business Wire
Checkpoint Capital L.P. Acquires Shares of 5,000 Corcept Therapeutics Incorporated $CORT - MarketBeat
Published on: 2025-09-08 19:18:57 - beatles.ru
Predicting Corcept Therapeutics Incorporated trend using moving averages2025 Price Momentum & Fast Exit Strategy with Risk Control - Newser
Canaccord Genuity Maintains a Buy on Corcept Therapeutics (CORT), Retains a $137 PT - MSN
Is Corcept Therapeutics Incorporated a good ESG investmentJuly 2025 Action & Entry Point Confirmation Alerts - خودرو بانک
Published on: 2025-09-06 00:29:23 - خودرو بانک
Ieq Capital LLC Buys 7,844 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Can Corcept Therapeutics Incorporated weather a recession2025 Trade Ideas & Free Safe Capital Growth Stock Tips - خودرو بانک
Corcept Therapeutics Incorporated stock retracement – recovery analysisQuarterly Profit Report & AI Forecasted Entry and Exit Points - Newser
predicting corcept therapeutics incorporated trend using moving averagesJuly 2025 Weekly Recap & Real-Time Chart Pattern Alerts - Newser
Can Corcept Therapeutics Incorporated hit a new high this monthJuly 2025 Short Interest & Safe Capital Allocation Plans - Newser
Is it time to cut losses on Corcept Therapeutics IncorporatedInsider Buying & Safe Capital Allocation Plans - Newser
Key resistance and support levels for Corcept Therapeutics IncorporatedDollar Strength & Reliable Intraday Trade Alerts - Newser
Assessing Insider Selling at Corcept Therapeutics: Strategic and Market Implications - AInvest
Corcept therapeutics CEO Belanoff sells $2.8m in shares By Investing.com - Investing.com Canada
Raymond James Financial Inc. Has $8.90 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics officer Maduck sells $1.4m in shares By Investing.com - Investing.com South Africa
Corcept therapeutics exec Guyer sells $1.4m in shares By Investing.com - Investing.com Canada
Corcept Therapeutics officer Maduck sells $1.4m in shares - Investing.com
Lyon of Corcept Therapeutics sells $351k in shares By Investing.com - Investing.com Canada
Corcept therapeutics exec Guyer sells $1.4m in shares - Investing.com India
Corcept therapeutics CEO Belanoff sells $2.8m in shares - Investing.com
Corcept Therapeutics Incorporated stock momentum explainedMarket Growth Summary & High Accuracy Trade Signal Alerts - Newser
Price momentum metrics for Corcept Therapeutics Incorporated explainedQuarterly Earnings Summary & Reliable Price Breakout Signals - Newser
259,650 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Driehaus Capital Management LLC - MarketBeat
How to track smart money flows in Corcept Therapeutics IncorporatedJuly 2025 Opening Moves & High Conviction Buy Zone Alerts - Newser
Pattern recognition hints at Corcept Therapeutics Incorporated upside2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Can momentum traders help lift Corcept Therapeutics IncorporatedPortfolio Update Report & Safe Capital Investment Plans - Newser
Published on: 2025-09-03 06:08:46 - Newser
Applying sector rotation models to Corcept Therapeutics Incorporated2025 Market WrapUp & High Accuracy Trade Signal Alerts - Newser
Will Corcept Therapeutics Incorporated benefit from geopolitical trendsQuarterly Market Summary & Long-Term Growth Plans - خودرو بانک
Published on: 2025-09-03 11:50:42 - خودرو بانک
Quantitative breakdown of Corcept Therapeutics Incorporated recent moveDay Trade & Stepwise Swing Trade Plans - Newser
What are the future prospects of Corcept Therapeutics IncorporatedJuly 2025 Summary & Safe Capital Growth Trade Ideas - خودرو بانک
Why is Corcept Therapeutics Incorporated stock going up2025 Price Momentum & Low Drawdown Trading Strategies - خودرو بانک
Corcept Therapeutics Inc (CORT) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):